<DOC>
	<DOCNO>NCT02063971</DOCNO>
	<brief_summary>The study evaluate tolerance efficacy skin comfort F # 1048-082 soothing cream use injection procedure also tolerance efficacy F # 841-020 anti-age cream age parameter compare baseline F # 1374-002 placebo cream ( comparison within subject - half face method ) identify additional benefit deliver product compare cosmetic procedure .</brief_summary>
	<brief_title>Tolerance Efficacy Evaluation 3 Face Creams</brief_title>
	<detailed_description>First study phase ( soothe activity ) - Clinical grading ( visual analogic scale ) : 1 . Erythema ( 0= erythema 10= strong erythema ) 2 . Oedema ( 0= oedema 10= strong oedema ) 3 . Bruise ( 0= bruise 10= strong bruise ) 4 . Overall skin appearance ( 0= bad overall appearance 10= good overall appearance ) . - Optical colorimetry : measurement redness/bruise ( L*a*b* ) Spectrophotometer CM-2600d . - Photographic documentation : Canfield image station equip visible , polarize , fluorescence UV light specific light shadow . Second study phase ( anti-age activity v placebo ) : - Clinical self grading ( visual analogic scale ) : 1 . Forehead wrinkle ( 0= wrinkle 10= severe wrinkle ) 2 . Crow 's foot wrinkle ( 0= wrinkle 10= severe wrinkle ) 3 . Crow 's foot fine line ( 0= fine line 10= severe fine line ) 4 . Under eye wrinkle ( 0= wrinkle 10= severe wrinkle ) 5 . Under eye fine line ( 0= fine line 10= severe fine line ) 6 . Frown line ( 0= wrinkle 10= severe wrinkle ) 7 . Marionette line ( 0= wrinkle 10= severe wrinkle ) 8 . Upper lip wrinkle ( 0= wrinkle 10= severe wrinkle ) 9 . Nasolabial fold ( 0= wrinkle 10= severe wrinkle ) 10 . Cheek wrinkle ( 0= wrinkle 10= severe wrinkle ) 11 . Neck wrinkle ( 0= wrinkle 10= severe wrinkle ) 12 . Lines neck opening ( 0= wrinkle 10= severe wrinkle ) 13 . Skin firmness ( 0= firm skin 10= firm skin ) 14 . Skin elasticity ( 0= elastic skin 10= elastic skin ) 15 . Sagging skin ( 0= sag skin 10= severe sag skin ) 16 . Radiance ( 0= radiant skin 10= radiant skin ) 17 . Smoothness ( 0= smooth skin 10= smooth skin ) 18 . Skin softness ( 0= soft skin 10= soft skin ) 19 . Colour evenness ( 0= good evenness 10= bad evenness ) 20 . Skin tone ( 0= good complexion 10= bad complexion ) - Optical colorimetry : measurement skin colour ( L*a*b* ) Spectrophotometer CM-2600d . - Photographic documentation : Canfield image station equip visible , polarize , fluorescence UV light specific light shadow . - Skin replicas profilometry level crow 's foot ( image analysis : total surface wrinkle , mean length wrinkle , total length wrinkle , number wrinkle ) - Skin elasticity measurement suction ( CutometerÂ® ) Tolerance evaluation ( investigator 's judgement ) : At evaluation time , investigator consider appearance possible adverse effect relate tested cream comment report subject diary card judge tolerance product study .</detailed_description>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>female gender age &gt; 35 year old good general state health woman already undergone Hyaluronic acid injection woman apply retinoid product last 3 month woman recovery period laser/peeling/acne treatment accept return centre plan visit accept follow investigator 's instruction entire study period agree present study visit without makeup accept change habit regard : food , physical activity , face cleanse makeup use agree receive drug able change skin characteristic entire duration study accept receive cutaneous antiage treatment entire duration study accept expose face strong UV irradiation ( UV session sun bathe ) entire duration study accept sign Informed consent form . Pregnancy ( subject menopause ) lactation ( subject menopause ) subject menopause use adequate contraceptive precaution order avoid pregnancy study ; subject menopause accept perform pregnancy test basal visit ( T0 ) , 6 12 week intradermal implant execution ; subject participate similar test le 3 month ago sensitivity test product ingredient subject whose insufficient adhesion study protocol foreseeable . dermatitis presence cutaneous disease test area lesion , scar , malformation . clinical significant skin condition test area ( e.g . active eczema , dermatitis , psoriasis etc . ) recurrent facial/labial herpes . diabetes endocrine disease hepatic disorder renal disorder cardiac disorder pulmonary disease digestive disease haematological disease chronic phlogosis autoimmune disease cancer neurological psychological disease drug allergy . systemic corticosteroid retinoid product previous 3 month entire study period aspirin nonsteroid antiinflammatory drug ( FANS ) antihistaminic , narcotic , antidepressant , immunosuppressive drug ( except , female subject , contraceptive hormonal treatment start least one year ) assumption drug able influence test result investigator opinion .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Skin age</keyword>
	<keyword>Soothing activity</keyword>
	<keyword>Hyaluronic acid injection</keyword>
</DOC>